Kyntra Bio to Present at the 25th Annual Needham Virtual Healthcare Conference
Kyntra Bio, Inc. (KYNB)
Company Research
Source: GlobeNewswire
SAN FRANCISCO, April 08, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio (Nasdaq: KYNB) today announced that the Company will present at the 25th Annual Needham Virtual Healthcare Conference being held April 13-16, 2026. Thane Wettig, Chief Executive Officer of Kyntra Bio, will deliver a company presentation on Monday, April 13, 2026, at 1:30 PM EDT. A live webcast of the presentation will be available here. Kyntra Bio’s management team will be available for one-on-one meetings during the conference. Interested investors should contact their representative at Needham. A replay of the presentation will be posted, when available, to the Kyntra Bio website on the Events & Presentations page of the Investors and Media section for 90 days. About Kyntra BioKyntra Bio is a biopharmaceutical company focused on development of novel therapies in oncology and rare disease. Roxadustat (???®, EVRENZO™) is currently approved in Europe, Japan, China, and numerous other countries for the treatment of anemia
Show less
Read more
Impact Snapshot
Event Time:
KYNB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KYNB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KYNB alerts
High impacting Kyntra Bio, Inc. news events
Weekly update
A roundup of the hottest topics
KYNB
News
- Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateGlobeNewswire
- Kyntra Bio to Report Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire
- Kyntra Bio (KYNB) was upgraded by HC Wainwright to "strong-buy".MarketBeat
- Kyntra Bio to Participate in Upcoming Investor ConferencesGlobeNewswire
- Kyntra Bio (NASDAQ:KYNB) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
KYNB
Earnings
- 3/16/26 - Beat
KYNB
Analyst Actions
- 2/28/26 - HC Wainwright